Head-to-head · WeighScore
MyDrHank vs Strut Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 68.2/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MyDrHank | Strut Health |
|---|---|---|
| WeighScore | 68.2/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #106 | #28 |
| Semaglutide | From $171/mo oral or injectable on GLP-1 lander; injection product page from $178/mo (conflicting offer terms; confirm) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | From $200/mo on GLP-1 lander; product page from $240/mo (conflicting offer terms; confirm) | From $199/mo either route |
| Coverage | Confirm prescription and state; contiguous-U.S. shipping claim does not establish individual eligibility | 49 states (not Arkansas) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #106 · C
Strengths
- Public landing and product pages show starting prices before medical intake
- Compounded injection options and a separate oral semaglutide menu are advertised, with formulation differences to discuss with the prescriber
- Product pages advertise consultation, delivery, check-ins and unlimited clinical messaging; response times were not tested
- Terms identify the platform operator and offer the current pharmacy-partner list on request
What to consider
- The GLP-1 lander shows $171/$200 injectable starting rates, while separate injection pages show $178/$240; applicable purchase terms remain unresolved
- Published base plan fields do not establish that a particular promotion is unavailable or what an individual will actually pay
- The reviewed GLP-1 terms did not establish the cancellation cutoff, unused-prepayment refund formula or declined-treatment financial outcome
- The assigned medical practice, prescriber and dispensing location remain unestablished; no current individual license verification is claimed
- Dose, concentration, usable supply, laboratory costs and state-specific availability require confirmation
- Compounded preparations are not FDA-approved; displayed branded-product trial results do not establish outcomes for these formulations
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
What to consider
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring program
- Compounded only, with no brand-name lane
- Not available in Arkansas
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.